Search by Drug Name or NDC
NDC 23155-0787-01 Acetazolamide 500 mg/1 Details
Acetazolamide 500 mg/1
Acetazolamide is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is ACETAZOLAMIDE.
MedlinePlus Drug Summary
Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Acetazolamide decreases the pressure in the eye. Acetazolamide is also used to reduce the severity and duration of symptoms (upset stomach, headache, shortness of breath, dizziness, drowsiness, and fatigue) of altitude (mountain) sickness. Acetazolamide is used with other medicines to reduce edema (excess fluid retention) and to help control seizures in certain types of epilepsy. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 23155-0787-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acetazolamide
Product Information
| NDC | 23155-0787 |
|---|---|
| Product ID | 23155-787_014ebddc-7e6b-4291-8899-65df122cc0bf |
| Associated GPIs | 37100010006920 |
| GCN Sequence Number | 008164 |
| GCN Sequence Number Description | acetazolamide CAPSULE ER 500 MG ORAL |
| HIC3 | R1E |
| HIC3 Description | CARBONIC ANHYDRASE INHIBITORS |
| GCN | 34700 |
| HICL Sequence Number | 003641 |
| HICL Sequence Number Description | ACETAZOLAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Acetazolamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetazolamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | ACETAZOLAMIDE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040904 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0787-01 (23155078701)
| NDC Package Code | 23155-787-01 |
|---|---|
| Billing NDC | 23155078701 |
| Package | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (23155-787-01) |
| Marketing Start Date | 2021-02-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.328 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ACETAZOLAMIDE ER 500 MG CAP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |